Preferred Drug List (PDL), Pharmacy & Therapeutics (P&T) and Drug Utilization Review (DUR) Committee

Pharmacy and Therapeutics (P&T) and Drug Utilization Review (DUR) Committee

In 2026, New Mexico Health Care Authority (HCA) implemented a statewide Preferred Drug List (PDL) designed to streamline medication access for Medicaid members and simplify prescribing practices.

HCA seeks qualified healthcare professionals to serve on the combined Pharmacy and Therapeutics (P&T) and Drug Utilization Review (DUR) Committee. The P&T/DUR Committee plays a critical role in ensuring safe, effective, and evidence-based use of medications within the state’s healthcare programs. Members review clinical evidence, provide recommendations to the Medicaid CMO, and develop guidance on pharmaceutical policies that impact patient care statewide.

Announcements

4th Quarter P&T/DUR meeting is scheduled for Tuesday, October 13, 2026 from 8:00 a.m. to 12:00 p.m.  If you have any questions or comments about the agenda please contact: Erika Ortega, Erika.Ortega@hca.nm.gov or Julie DiTucci-Reiter, Julie.DiTucci-Reiter@hca.nm.gov

Join: https://teams.microsoft.com/meet/247269192493726?p=ny1cocB3aMNblwhEvp
Meeting ID: 247 269 192 493 726
Passcode: 2Lv6w2bU

Dial in by phone
+1 505-312-4308,,819657104# United States, Albuquerque
(888) 506-1357,,819657104# United States (Toll-free)

Find a local number
Phone conference ID: 819 657 104#

Current PDL & FAQs

Date PostedTitle
10/15/2026NM PDL NDC List Excel
10/01/2026NM_PDL 7.1.26 Final
08/10/2026New Mexico PDL Listing
06/29/2026NM PDL FAQs

Meetings

Date PostedTitle
4/28/2026, 8:20:23 AMP&T DUR Agenda 4.13.26
5/12/2026, 4:26:20 PMPT-DUR Meeting Minutes 4.13.26 Approved
5/14/2026, 2:24:29 PMPT-DUR Meeting Slide Deck
Date PostedTitle
2/12/2026, 8:02:42 AMP&T DUR Agenda 1.16.2026
2/16/2026, 1:57:06 PMMeeting to Minutes 1.16.2026
2/12/2026, 8:02:42 AMSlide deck from Meeting 1,16.2026
2/17/2026, 10:49:17 AMBylaws of the Comb PandT and DUR for Preferred Drug List